Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed it enclosed copies of advertisement published on May 08, 2025, in ‘Business Standard’ (English) and ‘Business Standard’ (Hindi) newspaper providing Extracts of Standalone Audited financial Results of the Company for the quarter and year ended March 31, 2025.
The above information is a part of company’s filings submitted to BSE.